Linden-Lahti, Carita
Takala, Anna
Holmström, Anna-Riia
Airaksinen, Marja
Funding for this research was provided by:
Helsinki University Pharmacy
Suomen Kulttuurirahasto
University of Helsinki including Helsinki University Central Hospital
Article History
Received: 8 March 2023
Accepted: 29 June 2023
First Online: 10 July 2023
Declarations
:
: This study was retrospective register-based document analysis from authority data collected to supervisory purposes. According to Finnish National Board on Research Integrity, ethical approval is not needed for retrospective register-based study unless there is a special risk for information security in merging data or it is a medical study [CitationRef removed]. This study was not medical study that intervened to patient’s physical or mental integrity according to definition of Finnish Act on Medical Study (1999/488). According to Finnish Act on Secondary Use of Social and Health Information (552/2019), Valvira can give permission to use data including authoritative statements in research purposes that fulfils the legislative requirements. The study was granted a study approval from Valvira. The study was conducted under Valvira’s supervision and data has been pseudonymized for the purposes of this study analysis. Good research practice and data protection guidelines were followed throughout the research process [CitationRef removed, CitationRef removed].
: Because of the nature of register-based data collected to supervisory purposes and the use of data according to Finnish Act on Secondary Use of Social and Health Information (552/2019), consent for publication was not applicable. Valvira´s study approval included a statement that the results of the study are allowed to be presented in a way that specific patients, professionals or organizations are not recognized. Figure InternalRef removed, which includes the case description of ME is publicized under Valvira´s study approval and no patients, professionals or organizations included are recognizable<i>.</i>
: The authors declare no competing interests.